首页> 外国专利> COMPOSITIONS COMPRISING AT LEAST ONE POLYMETHOXYFLAVONE, FLAVONOID, LIMINOID, AND/OR TOCOTRIENOL USEFUL IN COMBINATION THERAPIES FOR TREATING DIABETES

COMPOSITIONS COMPRISING AT LEAST ONE POLYMETHOXYFLAVONE, FLAVONOID, LIMINOID, AND/OR TOCOTRIENOL USEFUL IN COMBINATION THERAPIES FOR TREATING DIABETES

机译:包含至少一种可用于治疗糖尿病的组合疗法中的至少一种多羟基黄酮,黄酮类,脂质体和/或生育三烯酚的组合物

摘要

Compositions comprising select natural products have been found to be useful as supplements to known medicaments for treating elevated blood glucose, HbAlc, blood pressure and cholesterol levels in persons suffering from metabolic syndrome, insulin resistance, and type 2 diabetes. The natural products of interest include polymethoxyflavones, flavonoids, liminoids, and tocotrienols, while the known medicaments include metformin. In preferred embodiments, the natural products are polymethoxyflavones found in citrus plants, such as nobiletin, tangeretin, and synephrin. Use of the natural product of interest will preferably result in HbAlc = 7%, LDL-C = 100 mg/dL, total cholesterol = 200 mg/dL; and systolic blood pressure = 130 mm Hg.
机译:已经发现包含精选天然产物的组合物可用作已知药物的补充剂,所述已知药物用于治疗患有代谢综合症,胰岛素抵抗和2型糖尿病的人的升高的血糖,HbAlc,血压和胆固醇水平。感兴趣的天然产物包括聚甲氧基黄酮,类黄酮,类脂质和生育三烯酚,而已知的药物包括二甲双胍。在优选的实施方案中,天然产物是在柑橘类植物中发现的聚甲氧基黄酮,例如诺比列汀,橘皮苷和新弗林蛋白。使用感兴趣的天然产物优选将导致HbAlc = 7%,LDL-C = 100 mg / dL,总胆固醇= 200 mg / dL;和收缩压= 130毫米汞柱。

著录项

  • 公开/公告号CA2915751A1

    专利类型

  • 公开/公告日2014-12-24

    原文格式PDF

  • 申请/专利权人 KGK SYNERGIZE INC.;

    申请/专利号CA20142915751

  • 发明设计人 GUTHRIE NAJLA;

    申请日2014-06-13

  • 分类号A61K31/352;A61K31/137;A61K31/355;A61K36/48;A61K36/752;A61P3/10;C07D311/30;A61K31/155;

  • 国家 CA

  • 入库时间 2022-08-21 15:11:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号